In the US, Temodar (temozolomide systemic) is a member of the drug class alkylating agents and is used to treat Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Glioblastoma Multiforme, Melanoma and Melanoma - Metastatic.
Ingredient matches for Temodar
Temozolomide is reported as an ingredient of Temodar in the following countries:
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.